MPLT R&D Expense Growth
Maplight Therapeutics Inc · R&D Expense Growth
MPLT R&D Expense Growth
Latest reported103.14%period ending
MPLT FY R&D Growth (YoY) (0.00% → 103.14%)
Latest values, visible window
High-resolution chart · PNG
MPLT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 103.1362% | |
| 38.0769% | |
| 84.8664% | |
| 0% |